Shahid Nimjee
I’m a Professor of Neurosurgery and a dual-trained neurological surgeon specializing in open and endovascular neurosurgery.
I also lead and NIH-funded research program studying acute thrombosis. Our lead program focuses on targeting Von Willebrand factor (VWF) with reversible RNA-based therapeutic effectively treat patients who currently don't qualify for pharmacological therapy, and at the same time, with a safety profile currently unavailable in the field.
Abstracts this author is presenting:
